Zdrowie i gospodarka · 15/08/2018

FDA Requests Public Comment on Proposed Collection of Information for Postmarketing Adverse Event Reporting

The Food and Drug Administration is seeking public input on a proposed collection of information related to postmarketing adverse event reporting for nonprescription human drug products marketed without FDA approval, as required by the Paperwork Reduction Act of 1995.